NCT01511471View on ClinicalTrials.gov

Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Platelet Reactivity
Interventions
DRUG

Ticagrelor

Ticagrelor 90mg twice a day for 15 days

Trial Locations (2)

26500

Agios Andreas General Hospital, Nephrology Department, Pátrai

Cardiology Department Patras University Hospital, Rio

All Listed Sponsors
lead

University of Patras

OTHER

NCT01511471 - Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis | Biotech Hunter | Biotech Hunter